Toxicity and anti-tumour efficacy of oxaliplatin on Glasgow Osteosarcoma in mice: A mathematical model;Toxicité et efficacité antitumorale de l'oxaliplatine sur l'ostéosarcome de Glasgow induit chez la souris: Un modèle mathématique

Pathologie Biologie

Volumn 51, Issue 4, 2003, Pages 212-215

  Clairambault, Jean ^a   Claude, Daniel ^b   Filipski, Elisabeth ^c   Granda, Teresa ^c   Lévi, Francis ^c  

^a INRIA ROCQUENCOURT   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c HÔPITAL PAUL BROUSSE   (France)

Author keywords

Chronotherapy; Theoretical Models; Treatment Outcome

Indexed keywords

CYTOTOXIC AGENT; OXALIPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; GROWTH INHIBITION; MATHEMATICAL MODEL; MOUSE; NONHUMAN; OSTEOSARCOMA; TREATMENT OUTCOME; TUMOR GROWTH;

EID: 0042815030     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(03)00045-2     Document Type: Conference Paper

References (8)

1. Granda TG, D'Attino R-M, Filipski E, et al. Circadian optimization of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma. Brit. J. Cancer 2002;86:999-1005.
2. Boughattas NA, Lévi F, et al. Circadian Rhythm in Toxicities and Tissue Uptake of 1,2-diamminocyclohexane(trans-1)oxaloplatinum(II) in Mice. Cancer Research 1989;49:3362-8.
3. Lévi F, Metzger G, Massari C, Milano G. Oxaliplatin: Pharmacokinetics and Chronopharmacological Aspects. Clin. Pharmacokinet. 2000;38:1-21.
4. Lévi F, Perpoint B, et al. Oxaliplatin Activity against Metastatic Colorectal Cancer. A Phase II Study of 5-Day Continuous Venous Infusion at Circadian Rhythm Modulated Rate. Eur J Cancer 1993;29A(9):1280-4.
5. Edelstein-Keshet L. Mathematical Models in Biology. N-Y: McGraw-Hill; 1988.
6. Goldie JH, Coldman AJ. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-33.
7. Wright N, Alison M. The biology of epithelial cell populations, Vol.2. Oxford: Clarendon Press; 1984 chap. 23.
8. Potten CS, Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 1990;110:1001-20.